The companies are collaborating to perfect the required marketing applications to the local regulatory authorities. It is anticipated that the marketing of Catrix wound dressing will commence in the fourth quarter of 2008.
According to Lescarden, this agreement extends their penetration into the Asian market for both Catrix based clinical skin care and wound care products.